Journal of Experimental & Clinical Cancer Research,
Journal Year:
2024,
Volume and Issue:
43(1)
Published: June 15, 2024
Abstract
PANoptosis
represents
a
novel
type
of
programmed
cell
death
(PCD)
with
distinctive
features
that
incorporate
elements
pyroptosis,
apoptosis,
and
necroptosis.
is
governed
by
newly
discovered
cytoplasmic
multimeric
protein
complex
known
as
the
PANoptosome.
Unlike
each
these
PCD
types
individually,
still
in
early
stages
research
warrants
further
exploration
its
specific
regulatory
mechanisms
primary
targets.
In
this
review,
we
provide
brief
overview
conceptual
framework
molecular
components
PANoptosis.
addition,
highlight
recent
advances
understanding
therapeutic
applications
By
elucidating
crosstalk
between
apoptosis
necroptosis
summarizing
functional
consequences
special
focus
on
tumor
immune
microenvironment,
review
aims
to
theoretical
basis
for
potential
application
cancer
therapy.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: Feb. 9, 2023
PANoptosis,
a
new
research
hotspot
at
the
moment,
is
cell
death
pattern
in
which
pyroptosis,
apoptosis,
and
necroptosis
all
occur
same
population.
In
essence,
PANoptosis
highly
coordinated
dynamically
balanced
programmed
inflammatory
pathway
that
combines
main
features
of
necroptosis.
Many
variables,
such
as
infection,
injury,
or
self-defect,
may
be
involved
occurrence
with
assembly
activation
PANoptosome
being
most
critical.
has
been
linked
to
development
multiple
systemic
diseases
human
body,
including
infectious
diseases,
cancer,
neurodegenerative
diseases.
Therefore,
it
necessary
clarify
process
occurrence,
regulatory
mechanism
its
relation
this
paper,
we
summarized
differences
relations
between
three
types
death,
emphatically
expounded
molecular
patterns
expectation
facilitating
application
regulation
disease
treatment.
Journal of Inflammation Research,
Journal Year:
2023,
Volume and Issue:
Volume 16, P. 1523 - 1532
Published: April 1, 2023
Abstract:
PANoptosis
is
a
new
cell
death
proposed
by
Malireddi
et
al
in
2019,
which
characterized
pyroptosis,
apoptosis
and
necroptosis,
but
cannot
be
explained
any
of
them
alone.
The
interaction
between
necroptosis
involved
PANoptosis.
In
this
review,
from
the
perspective
PANoptosis,
we
focus
on
relationship
key
molecules
process
formation
PANoptosome,
as
well
role
diseases.
We
aim
to
understand
mechanism
provide
basis
for
targeted
intervention
PANoptosis-related
treat
human
Keywords:
apoptosis,
Immunological Reviews,
Journal Year:
2023,
Volume and Issue:
321(1), P. 246 - 262
Published: Oct. 12, 2023
Summary
Cell
death
can
be
executed
through
distinct
subroutines.
PANoptosis
is
a
unique
inflammatory
cell
modality
involving
the
interactions
between
pyroptosis,
apoptosis,
and
necroptosis,
which
mediated
by
multifaceted
PANoptosome
complexes
assembled
via
integrating
components
from
other
modalities.
There
growing
interest
in
process
function
of
PANoptosis.
Accumulating
evidence
suggests
that
occurs
under
diverse
stimuli,
for
example,
viral
or
bacterial
infection,
cytokine
storm,
cancer.
Given
impact
across
disease
spectrum,
this
review
briefly
describes
relationships
highlights
key
molecules
formation
activation,
outlines
roles
diseases
together
with
potential
therapeutic
targeting.
We
also
discuss
important
concepts
pressing
issues
future
research.
Improved
understanding
its
mechanisms
crucial
identifying
novel
targets
strategies.
Cell Death and Disease,
Journal Year:
2023,
Volume and Issue:
14(12)
Published: Dec. 21, 2023
Abstract
Pyroptosis,
apoptosis,
and
necroptosis
are
mainly
programmed
cell
death
(PCD)
pathways
for
host
defense
homeostasis.
PANoptosis
is
a
newly
distinct
inflammatory
PCD
pathway
that
uniquely
regulated
by
multifaceted
PANoptosome
complexes
highlights
significant
crosstalk
coordination
among
pyroptosis
(P),
apoptosis
(A),
and/or
necroptosis(N).
Although
some
studies
have
focused
on
the
possible
role
of
PANpoptosis
in
diseases,
pathogenesis
complex
underestimated.
Furthermore,
progress
related
agonists
or
inhibitors
disorders
has
not
yet
been
thoroughly
discussed.
In
this
perspective,
we
provide
perspectives
context
diverse
pathological
conditions
human
diseases.
The
treatment
targeting
also
summarized.
conclusion,
involved
plenty
including
but
limited
to
microbial
infections,
cancers,
acute
lung
injury/acute
respiratory
distress
syndrome
(ALI/ARDS),
ischemia-reperfusion,
organic
failure.
seems
be
double-edged
sword
conditions,
as
induces
negative
impact
prognosis
like
COVID-19
ALI/ARDS,
while
provides
protection
from
HSV1
Francisella
novicida
infection,
kills
cancer
cells
suppresses
tumor
growth
colorectal
cancer,
adrenocortical
carcinoma,
other
cancers.
Compounds
endogenous
molecules
promising
therapeutic
strategies,
which
can
act
PANoptosomes-associated
members
regulate
PANoptosis.
More
researches
needed
better
understand
pathology
develop
treatment.
Cancer Gene Therapy,
Journal Year:
2024,
Volume and Issue:
31(7), P. 970 - 983
Published: March 29, 2024
Abstract
This
comprehensive
review
explores
the
intricate
mechanisms
of
PANoptosis
and
its
implications
in
cancer.
PANoptosis,
a
convergence
apoptosis,
pyroptosis,
necroptosis,
plays
crucial
role
cell
death
immune
response
regulation.
The
study
delves
into
molecular
pathways
each
mechanism
their
crosstalk
within
emphasizing
shared
components
like
caspases
PANoptosome
complex.
It
highlights
significant
various
cancers,
including
respiratory,
digestive,
genitourinary,
gliomas,
breast
showing
impact
on
tumorigenesis
patient
survival
rates.
We
further
discuss
interwoven
relationship
between
tumor
microenvironment
(TME),
illustrating
how
influences
behavior
progression.
underscores
dynamic
interplay
tumors
microenvironments,
focusing
roles
different
cells
interactions
with
cancer
cells.
Moreover,
presents
new
breakthroughs
therapy,
potential
targeting
to
enhance
anti-tumor
immunity.
outlines
strategies
manipulate
for
therapeutic
purposes,
such
as
key
signaling
molecules
caspases,
NLRP3,
RIPK1,
RIPK3.
novel
treatments
immunogenic
PANoptosis-initiated
therapies
nanoparticle-based
is
also
explored.
Biomedicine & Pharmacotherapy,
Journal Year:
2023,
Volume and Issue:
168, P. 115802 - 115802
Published: Oct. 31, 2023
Diabetes
mellitus
is
a
metabolic
disease
caused
by
disorders
of
insulin
secretion
and
utilization.
Long-term
hyperglycemia,
resistance,
glucose
lipid
metabolism
cause
vascular
endothelial
cell
damage.
Endothelial
dysfunction
key
feature
diabetic
complications
such
as
nephropathy,
retinopathy,
neuropathy,
atherosclerosis.
Importantly,
death
thought
to
be
factor
contributing
injury.
Morphologically,
can
divided
into
three
forms:
type
I
apoptosis,
II
autophagy,
III
necrosis.
According
the
difference
in
function,
accidental
(ACD)
regulated
(RCD).
RCD
controlled
process
involving
numerous
proteins
precise
signaling
cascades.
Multiple
subroutines
covered
may
involved
dysfunction,
including
necroptosis,
pyroptosis,
entosis,
ferroptosis,
ferroautophagy,
parthanatos,
netotic
death,
lysosome-dependent
alkaliptosis,
oxeiptosis,
cuproptosis,
PANoptosis.
This
article
briefly
reviews
mechanism
significance
associated
with
which
will
help
deepen
understanding
provide
new
therapeutic
ideas.
Theranostics,
Journal Year:
2023,
Volume and Issue:
14(2), P. 640 - 661
Published: Dec. 26, 2023
Regulated
cell
death
(RCD)
is
considered
a
critical
pathway
in
cancer
therapy,
contributing
to
eliminating
cells
and
influencing
treatment
outcomes.
The
application
of
RCD
marked
by
its
potential
targeted
therapy
immunotherapy.
As
type
RCD,
PANoptosis
has
emerged
as
unique
form
programmed
(PCD)
characterized
features
pyroptosis,
apoptosis,
necroptosis
but
cannot
be
fully
explained
any
these
pathways
alone.
It
regulated
multi-protein
complex
called
the
PANoptosome.
relatively
new
concept
first
described
2019,
been
shown
play
role
many
diseases,
including
cancer,
infection,
inflammation.
This
study
reviews
PCD
particularly
emergence
implication
developing
therapeutic
strategies
for
cancer.
Studies
have
that
characterization
patterns
can
predict
survival
response
immunotherapy
chemotherapy,
highlighting
used
target
treatment.
also
plays
limiting
spread
cells.
allows
elimination
multiple
address
various
challenges
treatment,
drug
resistance
immune
evasion.
Moreover,
active
investigation
mechanisms
agents
induce
likely
yield
effective
treatments
improve
patient
Research
on
still
ongoing,
it
rapidly
evolving
field
with
lead
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: June 15, 2023
Hepatocellular
carcinoma
(HCC)
is
a
highly
prevalent
and
fatal
cancer.
The
role
of
PANoptosis,
novel
form
programmed
cell
death,
in
HCC
yet
to
be
fully
understood.
This
study
focuses
on
identifying
analyzing
PANoptosis-associated
differentially
expressed
genes
(HPAN_DEGs),
aiming
enhance
our
understanding
pathogenesis
potential
treatment
strategies.We
analyzed
from
TCGA
IGCG
databases
mapped
them
the
PANoptosis
gene
set,
69
HPAN_DEGs.
These
underwent
enrichment
analyses,
consensus
clustering
analysis
was
used
determine
three
distinct
subgroups
based
their
expression
profiles.
immune
characteristics
mutation
landscape
these
were
evaluated,
drug
sensitivity
predicted
using
HPAN-index
relevant
databases.The
HPAN_DEGs
mainly
enriched
pathways
associated
with
cycle,
DNA
damage,
Drug
metabolism,
Cytokines,
Immune
receptors.
We
identified
subtypes
(Cluster_1,
SFN+PDK4-;
Cluster_2,
SFN-PDK4+;
Cluster_3,
SFN/PDK4
intermediate
expression)
profiles
exhibited
clinical
outcomes,
characteristics,
landscapes.
HPAN-index,
generated
by
machine
learning
levels
HPAN_DEGs,
as
an
independent
prognostic
factor
for
HCC.
Moreover,
high
group
response
immunotherapy,
while
low
showed
small
molecule
targeted
drugs.
Notably,
we
observed
that
YWHAB
plays
significant
Sorafenib
resistance.This
crucial
tumor
growth,
infiltration,
resistance
Additionally,
discovered
constructed
predict
immunotherapeutic
sensitivity.
Our
findings
underscore
resistance,
presenting
valuable
insights
personalized
therapeutic
strategy
development